Search results
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 4 days agoPrevnar sales inched 2% ahead to $6.44 billion. But other key products saw downfalls. Revenue from...
Amgen Inc. (NASDAQ:AMGN) Stock Position Decreased by PSI Advisors LLC
ETF DAILY NEWS· 6 days agoPSI Advisors LLC lessened its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 31.8% in the fourth quarter, according to the company in its most recent filing with the Securities ...
Brokerages Set Biogen Inc. (NASDAQ:BIIB) Price Target at $295.58
ETF DAILY NEWS· 2 days agoShares of Biogen Inc. (NASDAQ:BIIB – Get Free Report) have earned a consensus rating of “Moderate Buy” from the twenty-seven research firms that are covering the company, Marketbeat reports.
Biogen (NASDAQ:BIIB) Sees Unusually-High Trading Volume on Earnings Beat
ETF DAILY NEWS· 2 days agoBiogen Inc. (NASDAQ:BIIB – Get Free Report) shares saw strong trading volume on Wednesday following a better than expected earnings announcement. Biogen had a net margin of 12.07% and a return ...
Biogen (BIIB) Scheduled to Post Quarterly Earnings on Wednesday
ETF DAILY NEWS· 6 days agoBiogen (NASDAQ:BIIB – Get Free Report) will be announcing its earnings results before the market opens on Wednesday, April 24th. Analysts expect the company to announce earnings of $3.48 per ...
Needham & Company LLC Reiterates Buy Rating for Biogen (NASDAQ:BIIB)
ETF DAILY NEWS· 2 days agoBiogen (NASDAQ:BIIB – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at Needham & Company LLC in a research note issued to investors on Wednesday, Benzinga reports ...
Knights of Columbus Asset Advisors LLC Buys 2,800 Shares of Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 6 days agoKnights of Columbus Asset Advisors LLC raised its position in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 97.9% during the fourth quarter, according to its most recent Form 13F filing ...